SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Meridian Investment Counsel Inc.

Meridian Investment Counsel Inc. trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 13,777 shares of the exchange traded fund’s stock after selling 1,760 shares during the period. Meridian Investment Counsel Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,361,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Fifth Third Bancorp boosted its stake in shares of SPDR S&P Biotech ETF by 3.4% in the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock valued at $10,968,000 after buying an additional 3,922 shares during the period. Avantax Advisory Services Inc. lifted its stake in SPDR S&P Biotech ETF by 17.2% in the first quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock worth $913,000 after acquiring an additional 1,415 shares during the last quarter. PFG Investments LLC grew its holdings in SPDR S&P Biotech ETF by 9.2% during the 2nd quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock worth $2,303,000 after acquiring an additional 2,097 shares in the last quarter. IFG Advisory LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $241,000. Finally, Atria Wealth Solutions Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 56.1% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock valued at $1,539,000 after purchasing an additional 5,962 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 5.2 %

Shares of XBI stock opened at $91.88 on Friday. The company has a market cap of $7.00 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm has a fifty day moving average price of $98.95 and a 200 day moving average price of $96.03. SPDR S&P Biotech ETF has a 12 month low of $69.32 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.